ArticleOrphanet journal of rare diseases2021

Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome Survey (HOS).

Joseph Muenzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.